CTSB and breast cancer: Selective action of Al-ProD was studied in breast cancer cells and cardiomyocytes, indicating differential levels of cathepsin B. The in vivo pharmacokinetics and tumor regression effect with minimal toxicity were also carried out in breast cancer models.